An endogenous MPTP-like dopaminergic neurotoxin, N-methyl(R)salsolinol, in the cerebrospinal fluid decreases with progression of Parkinson's disease

Neuroscience Letters

Volumn 262, Issue 1, 1999, Pages 13-16

  Maruyama, Wakako ^a   Abe, Takashi ^b   Tohgi, Hideo ^b   Naoi, Makoto ^c  

^a Lab of Biochemistry and Metabolism   (Japan)

^b IWATE MEDICAL UNIVERSITY   (Japan)

^c Institute of Applied Biochemistry   (Japan)

Author keywords

Biomarker; Cerebrospinal fluid; L DOPA therapy; N Methyl(R)salsolinol; Neurotoxin; Parkinson's disease

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DOPAMINE; HOMOVANILLIC ACID; LEVODOPA; METHYLTRANSFERASE; N METHYLSALSOLINOL; NEUROTOXIN; SALSOLINOL; UNCLASSIFIED DRUG;

ADULT; AGED; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; DISEASE MARKER; DOPAMINE METABOLISM; DOPAMINERGIC NERVE CELL; FEMALE; HUMAN; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; REVIEW;

EID: 0033605337     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00003-8     Document Type: Article

References (17)

1. Anglade P., Vyas S., Javoy-Agid F., Herrero M.T., Michel P.P., Marquez J., Mouatt-Prigent A., Ruberg M., Hirsch E.C., Agid Y. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol. Histopathol. 12:1997;25-31.
2. Dostert P., Strolin Benedetti M., Dedieu M. Ratio of enantiomers of salsolinol in human urine. Pharmacol. Toxicol. 60(1):1993;13.
3. Dostert P., Strolin Benedetti M., Dordain G., Vernay D. Enantiometric composition of urinary salsolinol in Parkinsonian patients after Madopar. J. Neural Transm. PD Sect. 1:1989;61-74.
4. Langston J.W. Epidemiology versus genetics in Parkinson's disease: progress in resolving an age-old debate. Ann. Neurol. 44(11):1998;S45-S52.
5. Maruyama W., Abe T., Tohgi H., Dostert P., Naoi M. A dopaminergic neurotoxin, (R)-N-methylsalsolinol, increases in parkinsonian CSF. Ann. Neurol. 40:1996;119-122.
6. Maruyama W., Dostert P., Matsubara K., Naoi M. N-Methyl(R)salsolinol produces hydroxyl radicals: Involvement to neurotoxicity. Free Rad. Biol. Med. 19:1995;67-75.
7. Maruyama W., Naoi M., Kasamatsu T., Hashizume Y., Kohda K., Dostert P. An endogenous dopaminergic neurotoxin, N-methyl-(R)-salsolinol, induces DNA damage in human dopaminergic neuroblastoma SH-SY5Y cells. J. Neurochem. 69:1997;322-329.
8. Maruyama W., Narabayashi H., Dostert P., Naoi M. Stereospecific occurrence of a parkinsonism-inducing catechol isoquinoline, N-methyl(R)salsolinol, in the human intraventricular fluid. J. Neural Transm. 103:1996;1069-1076.
9. Maruyama W., Sobue G., Matsubara K., Hashizume Y., Dostert P., Naoi M. A dopaminergic neurotoxin, 1(R),2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, N-methyl(R)salsolinol, and its oxidation product, 1,2(N)-dimethyl-6,7-dihydroxyisoquinolinium ion, accumulate in the nigro-striatal system in the human brain. Neurosci. Lett. 223:1997;61-64.
10. Mizuno Y., Yoshino H., Ikebe S., Hattori N., Kobayashi T., Shimoda-Matsubayashi S., Matsumine H., Kondo T. Mitochondrial dysfunction in Parkinson's disease. Ann. Neurol. 44(1):1998;S45-S52.
11. Moser A., Scholz J., Nobbe F., Vieregge P., Böhme V., Bamberg H. Presence of N-methyl-norsalsolinol in the CSF: correlation with dopamine metabolites of patients with Parkinson's disease. J. Neurol. Sci. 131:1995;183-189.
12. Naoi M., Maruyama W., Dostert P., Hashizume Y., Nakahara D., Takahashi T., Ota M. Dopamine-derived endogenous 1(R),2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, N-methyl-(R)-salsolinol, induced parkinsonism in rat: biochemical, pathological and behavioral studies. Brain Res. 709:1996;285-295.
13. Naoi M., Maruyama W., Dostert P., Kohda K., Kaiya T. A novel enzyme enantio-selectively synthesizes (R)salsolinol, a precursor of a dopaminergic neurotoxin, N-methyl(R)salsolinol. Neurosci. Lett. 212:1996;183-186.
14. +-like neurotoxin, 1,2-dimethyl-6,7-dihydroxyisoquinolinium ion, in the substantia nigra of human brain. Neurosci. Lett. 235:1997;81-84.
15. Naoi M., Maruyama W., Zhang J.H., Takahashi T., Deng Y., Dostert P. Enzymatic oxidation of a dopaminergic neurotoxin, 1(R),2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, into 1,2(N)-dimethyl-6,7-dihydroxyisoquinolinium ion. Life Sci. 57:1995;1061-1066.
16. Naoi M., Maruyama W., Nakao N., Ibi T., Sahashi K., Strolin Benedetti M. (R)Salsolinol N-methyltransferase activity increases in parkinsonian lymphocytes. Ann. Neurol. 43:1998;212-216.
17. Origitano T., Hannigan J., Collins M.A. Rat brain salsolinol and blood-brain barrier. Brain Res. 224:1981;446-451.